Indianapolis, IN, United States of America

Michael Alan Robertson




Average Co-Inventor Count = 7.9

ph-index = 3

Forward Citations = 53(Granted Patents)


Company Filing History:


Years Active: 2007-2012

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Unveiling the Innovations of Michael Alan Robertson

Introduction:

Michael Alan Robertson is a distinguished inventor based in Indianapolis, IN, United States. With an impressive portfolio of 6 patents under his name, he has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Type II diabetes.

Latest Patents:

1. Pyridine derivatives as dipeptedyl peptidase inhibitors: Robertson's groundbreaking invention involves compounds that act as inhibitors of the DPP-IV enzyme for treating or preventing conditions like Type II diabetes.

2. 1-amino linked compounds: Another innovative patent by Robertson, these compounds serve as inhibitors of the DPP-IV enzyme, offering promising solutions in the realm of diabetes treatment.

Career Highlights:

Michael Alan Robertson is an integral part of the renowned pharmaceutical company Eli Lilly and Company. His innovative research and patents have helped propel the company's advancements in the field of medicine, especially in addressing diabetes-related challenges.

Collaborations:

Alongside his individual achievements, Robertson has collaborated closely with esteemed professionals in the industry. Two of his notable coworkers include Kenneth Allen Savin and Larry C Blaszczak. Through these collaborations, Robertson has been able to synergize his expertise and contribute to groundbreaking innovations in the pharmaceutical domain.

Conclusion:

In conclusion, Michael Alan Robertson's inventive spirit and dedication to advancing pharmaceutical research have not only earned him recognition but have also significantly impacted the landscape of diabetes treatment. His patents stand as a testament to his commitment to innovation and improving healthcare outcomes for individuals worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…